Access! 2025 Recap: A Call to Action for the Future of Generics and Biosimilars
The second and final day of Access! 2025 reinforced the urgency of addressing the challenges facing the generics and biosimilars industry. Amid growing political scrutiny, regulatory uncertainty, and shifting market dynamics, speakers and panelists highlighted the industry’s vital role in ensuring access to affordable medicines. From biosimilar adoption and PBM reform to FDA regulatory risks […]
Your All ACCESS! Pass
ACCESS! 2025 Day 1 Recap: Meeting the Moment and Navigating Uncertainty The opening day of Access! 2025 set the stage for an urgent and forward-looking discussion on the state of the generics and biosimilars industry. Against the backdrop of major news events—including the Trump administration’s proposed and paused tariffs, and Robert F. Kennedy Jr.’s nomination […]
4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need
Originally published by Direct Relief on May 11, 2023. Direct Relief announced today that it received a donation of 2 million doses of generic medications for nonprofit healthcare providers in the U.S. and globally, thanks to the Association of Accessible Medicines’ (AAM) 4GRxANTED campaign. Launched in February, the 4GRxANTED campaign invites people to record a video […]
Shamekka Shares Why We Should Never Take Moms #4GRxANTED
While everyone agrees that moms are more than deserving of a day that celebrates them and all they do, for many people, including Bay Area-based Shamekka Marty, Mother’s Day can be difficult. Shamekka lost her mother to complications from lupus when she was just 21 years old. For years, she helped care for her mom […]
AAM Voices of Access
Your Voices, Your Health AAM’s “Voices of Access” report features patients across the country speaking about the importance of generic and biosimilar medicines in their lives. This annual publication tells the impact that accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives. Download Report View Patient […]
October’s Story – Savings from Generic Medicines
When people have the foundation of health, they’re able to do more, be more and reach their potential. Just ask October (26) of New Carrollton, Maryland. “I have been taking generics and with the savings I’ve been able to put the money towards therapy sessions and other activities that would help my mental health.” October […]
New Social Media Campaign Unveiled to Raise Awareness of the Essential Role of Generic Medicine in Americans’ Lives
#4GRxANTED Campaign Will Expand Donations of Generic Medicines to Communities in Need WASHINGTON D.C. (February 15, 2023) – The members of the Association for Accessible Medicines (AAM), today announced the start of an industry-wide effort to remind everyone across the nation not to take the generic medicines they rely on daily – and the savings […]
Desi is Back Playing Soccer and Doing “Normal Kid” Stuff
When Desi’s swollen ankle began hurting so much that he was unable to run and keep up with his friends, his parents, Jonathan and Susan of Maryland, became concerned. After several doctor visits, a rheumatologist diagnosed Desi with juvenile idiopathic arthritis (JIA), an autoimmune disease. To help manage the symptoms of JIA, Desi receives weekly […]
Raising Awareness for Biosimilars for Stakeholders Around the World
Monday November 14, 2022 Washington, D.C. (November 14, 2022) – AAM’s Biosimilars Council and other members of the International Generic and Biosimilar Medicines Association (IGBA) are working to increase awareness of biosimilars through the third annual Global Biosimilars Week, which takes place November 14-18. AAM’s Senior Director of Marketing, Erica Klinger, serves as the IGBA […]
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek
Steve Selde, Director of the Biosimilars Council, a division of the Association of Accessible Medicines (AAM), joins Eileen to celebrate #GlobalBiosimilarsWeek and catch up with her since she last shared her biosimilar experience. View Eileen’s story on the AAM blog: https://biosimilarscouncil.org/resource/singing-dancing-and-taking-care-of-herself-with-biosimilars/ Learn more about the annual IGBA global education initiative at https://www.globalbiosimilarsweek.org/ If you are […]
October Can Now Afford to do More to Support Her Mental Health
In 2017, October felt her anxiety and panic attacks developing into something more serious: Her life, work, and relationships seemed meaningless. Realizing she needed help, October, age 26, sought in-hospital treatment in Maryland and was diagnosed with anxiety and chronic depression. She was started on a brand-name antidepressant; but after a change in health insurance […]
Teva USA is #RemarkablyGeneric
As AAM journeys across the country with our Generics Are the Solution (GATS) tour, we pay a visit to Teva Pharmaceuticals USA, Inc. in Parsippany, NJ. The Teva team shares with us their commitment to patient access, safety, quality and affordability. “When a generic company wins a patent litigation, it’s like David beating Goliath. The […]
